Sumitomo Pharma America (SMPA) is deeply committed to accelerating scientific and therapeutic breakthroughs to support patient-first outcomes in areas of critical need, including psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies.

More Information:

• • Prostate Cancer Playbook

Social Media Accounts

• • LinkedIn

Contact Person:

Maria Calkins
Director, Advocacy Prostate Cancer
maria.calkins@us.sumitomo-pharma.com